Livingston Alex
Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, SK S7N5B4, Canada.
Handb Exp Pharmacol. 2010(199):159-89. doi: 10.1007/978-3-642-10324-7_7.
The biggest challenge to the use of analgesic agents in animals is the determination of the efficacy of these agents. In humans, the verbal communication of the alleviation of pain is fundamental to the effective use of analgesics. In animals, the lack of verbal communication not only confounds the diagnosis and characterisation of the experience of pain, but also challenges the evaluation of the analgesic therapy. As animals possess the same neuronal pathways and neurotransmitter receptors as humans, it seems reasonable to expect that their perceptions of painful stimuli will be similar, and this is a basis for the use of laboratory animals for screening of analgesics for human use. However, as the evaluation in the laboratory animal tests is based mainly on behavioural responses, and although some physiological responses do occur, it is often difficult to separate these from stress responses. The use of behavioural responses to evaluate analgesics in a range of species is complicated by the fact that different species show different behaviours to a similar pain stimulus, and different pain stimuli produce different pain responses in the same species. Thus behaviours may be species- and pain-specific and this can complicate analgesic evaluation. As most animals possess similar neuronal mechanisms to humans for pain perception, it is not surprising that the standard human pain control strategies can be applied to animals. For instance, local anaesthetics, opioids, non-steroidal anti-inflammatory drugs (NSAIDs), as well as other analgesics used in humans are all found to be effective for animal use. Differences in metabolism and distribution between various species, as well as financial considerations in larger animals can affect efficacy and thus limit their use. In addition, the use of any drug in a species that may be intended for human consumption will be limited by residue considerations. The treatment of pain in animals presents many challenges, but the increasing public concerns regarding animal welfare will ensure that studies into the nature and control of animal pain will continue to have a high profile.
在动物中使用镇痛剂面临的最大挑战是确定这些药物的疗效。在人类中,疼痛缓解的言语交流是有效使用镇痛药的基础。在动物中,缺乏言语交流不仅使疼痛体验的诊断和特征描述变得复杂,也给镇痛治疗的评估带来了挑战。由于动物拥有与人类相同的神经通路和神经递质受体,因此可以合理预期它们对疼痛刺激的感知会相似,这也是使用实验动物筛选供人类使用的镇痛药的基础。然而,由于实验动物测试中的评估主要基于行为反应,尽管确实会出现一些生理反应,但往往很难将这些反应与应激反应区分开来。在一系列物种中使用行为反应来评估镇痛药很复杂,因为不同物种对相似的疼痛刺激表现出不同的行为,并且不同的疼痛刺激在同一物种中会产生不同的疼痛反应。因此,行为可能具有物种特异性和疼痛特异性,这会使镇痛评估变得复杂。由于大多数动物在疼痛感知方面具有与人类相似的神经机制,因此标准的人类疼痛控制策略可应用于动物也就不足为奇了。例如,局部麻醉药、阿片类药物、非甾体抗炎药(NSAIDs)以及人类使用的其他镇痛药都被发现对动物有效。不同物种之间代谢和分布的差异,以及大型动物的经济因素会影响疗效,从而限制它们的使用。此外,在可能供人类食用的物种中使用任何药物都会受到残留问题的限制。动物疼痛的治疗面临许多挑战,但公众对动物福利的日益关注将确保对动物疼痛的性质和控制的研究将继续备受关注。